Sanofi Menactra Meningococcal Vaccine from Japan
Menactra protects against Neisseria meningitidis serogroups A, C, Y, W-135 via polysaccharide-protein conjugates. Its retail syringe packaging for measured doses classifies it under HTS 3002.15.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Verify conjugate integrity; include protein/polysaccharide ratio certificates
• EUAs for emergency import; track pediatric vs adult formulations